Now hiring? Healthcare execs say AI will lead to more job opportunities

The continued evolution of AI will lead to more job opportunities in the healthcare industry, according to new survey of high-ranking executives. Investments in AI and the implementation of AI-focused strategies are both also on the rise.  

The survey was conducted by Optum, a healthcare technology company that is a part of UnitedHealth Group. Responses came from 500 executives representing hospitals, health insurance providers, life sciences organizations and employers from throughout the industry.

While a majority—52%––of respondents said they expect AI to create more job opportunities, 87% agreed with the idea that experience with AI is a top priority when making hiring decisions. In addition, 89% of respondents don’t think employees are currently being trained to use AI quickly enough.

Optum’s survey also found that investments in AI are up significantly compared to just one year ago. Investments are escalating, with respondents reporting an average net increase of $7.3 million compared to 2018, and 9 in 10 leaders who responded to the survey said they are confident they’ll see a return on AI-related investments earlier than they had previously believed.

Also, 62% of respondents indicated that their organizations have implemented an AI strategy, up 88% compared to 2018.

“These findings validate that AI is vital to holistically transform health care,” Dan Schumacher, president and chief operating officer of Optum, said in a prepared statement. “It’s encouraging to see executives’ growing trust in, and adoption of, AI to make data more actionable in making the health system work better for everyone.”

“In order to transform and modernize the U.S. health system through the power of AI, it is critical that organizations invest in developing talent throughout the enterprise to solve health care’s most complex challenges,” Steve Griffiths, senior vice president and chief operating officer of Optum Enterprise Analytics, said in the same statement.

Data for the second annual OptumIQ Survey on AI in Health Care was collected from Aug. 19 to Sept. 3, 2019. A fact sheet about the survey is available on Optum’s website.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.